These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


402 related items for PubMed ID: 14675046

  • 1. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP, Bledsoe SB, Smith SB, Bushinsky DA.
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [Abstract] [Full Text] [Related]

  • 2. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL.
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [Abstract] [Full Text] [Related]

  • 3. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR.
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [Abstract] [Full Text] [Related]

  • 4. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Parker WR, Asplin JR.
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [Abstract] [Full Text] [Related]

  • 5. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization.
    Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM.
    Kidney Int; 2005 Jul; 68(1):145-54. PubMed ID: 15954903
    [Abstract] [Full Text] [Related]

  • 6. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Laplante K, Asplin JR.
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [Abstract] [Full Text] [Related]

  • 7. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD.
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [Abstract] [Full Text] [Related]

  • 8. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD, Nanci A, Khan SR.
    J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
    [Abstract] [Full Text] [Related]

  • 9. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR, Glenton PA, Byer KJ.
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [Abstract] [Full Text] [Related]

  • 10. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
    Liu CJ, Tsai YS, Huang HS.
    Int J Mol Sci; 2022 Mar 11; 23(6):. PubMed ID: 35328466
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H.
    J Urol; 2001 Sep 11; 166(3):1078-82. PubMed ID: 11490302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA, Neumann KJ, Asplin J, Krieger NS.
    Kidney Int; 1999 Jan 11; 55(1):234-43. PubMed ID: 9893132
    [Abstract] [Full Text] [Related]

  • 15. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
    Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ.
    Kidney Int; 2007 Dec 11; 72(12):1503-11. PubMed ID: 17898697
    [Abstract] [Full Text] [Related]

  • 16. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis.
    Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA.
    J Urol; 2002 Sep 11; 168(3):1173-81. PubMed ID: 12187263
    [Abstract] [Full Text] [Related]

  • 17. Renal osteopontin expression in experimental urolithiasis.
    Yagisawa T, Chandhoke PS, Fan J, Lucia S.
    J Endourol; 1998 Apr 11; 12(2):171-6. PubMed ID: 9607445
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Li Q, Krieger NS, Yang L, Asplin J, Bushinsky DA.
    Nephron; 2024 Apr 11; 148(7):480-486. PubMed ID: 38262368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.